R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells

[1]  M. Schachner,et al.  Honokiol Eliminates Glioma/Glioblastoma Stem Cell-Like Cells via JAK-STAT3 Signaling and Inhibits Tumor Progression by Targeting Epidermal Growth Factor Receptor , 2018, Cancers.

[2]  You-hong Cui,et al.  VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells , 2018, Cell Death & Disease.

[3]  A. Markham.  Fostamatinib: First Global Approval , 2018, Drugs.

[4]  Jiří Mayer,et al.  Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials , 2018, American journal of hematology.

[5]  H. Hotz,et al.  SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment , 2018, Neuro-oncology.

[6]  A. Hjelmeland,et al.  The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells. , 2018, Biochimica et biophysica acta. Reviews on cancer.

[7]  Yingying Liu,et al.  HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway. , 2018, Cancer letters.

[8]  F. Lieberman,et al.  Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial , 2017, JAMA.

[9]  Yi-Hong Zhou,et al.  Tracking Functional Tumor Cell Subpopulations of Malignant Glioma by Phasor Fluorescence Lifetime Imaging Microscopy of NADH , 2017, Cancers.

[10]  A. Giatromanolaki,et al.  Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide. , 2017, Biochemical and biophysical research communications.

[11]  Yinsheng Chen,et al.  Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging , 2017, Neuro-oncology.

[12]  A. Toker,et al.  AKT/PKB Signaling: Navigating the Network , 2017, Cell.

[13]  Shiyuan Cheng,et al.  The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes , 2017, Cell reports.

[14]  W. Cui,et al.  Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination , 2016, Development.

[15]  Weiwei Yang,et al.  PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis , 2016, Nature Communications.

[16]  L. Laurenti,et al.  BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199. , 2016, Blood.

[17]  Min Zhang,et al.  Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition , 2016, Leukemia.

[18]  G. Tsokos,et al.  Targeting Syk in Autoimmune Rheumatic Diseases , 2016, Front. Immunol..

[19]  Hyung-Ryong Kim,et al.  Endoplasmic Reticulum Stress and Associated ROS , 2016, International journal of molecular sciences.

[20]  May Yin Lee,et al.  Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity , 2015, Nature.

[21]  R. Koerber,et al.  Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma , 2015, Experimental Hematology & Oncology.

[22]  P. Marin,et al.  Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis* , 2015, The Journal of Biological Chemistry.

[23]  P. Schumacker,et al.  Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? , 2014, Nature Reviews Cancer.

[24]  Yinsheng Chen,et al.  Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells. , 2014, The American journal of Chinese medicine.

[25]  T. Maeda,et al.  Acidic extracellular microenvironment and cancer , 2013, Cancer Cell International.

[26]  L. Parada,et al.  Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells , 2012, Cell.

[27]  K. Aldape,et al.  Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway , 2012, Journal of Neuro-Oncology.

[28]  J. Ricci,et al.  Cancer metabolism: current perspectives and future directions , 2012, Cell Death and Disease.

[29]  L. Laurenti,et al.  The Syk kinase as a therapeutic target in leukemia and lymphoma , 2011, Expert opinion on investigational drugs.

[30]  Victor L. J. Tybulewicz,et al.  The SYK tyrosine kinase: a crucial player in diverse biological functions , 2010, Nature Reviews Immunology.

[31]  S. Stilgenbauer,et al.  Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia. , 2009, Blood.

[32]  J. Bussel,et al.  Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk. , 2009, Blood.

[33]  M. Weinblatt,et al.  Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial. , 2008, Arthritis and rheumatism.

[34]  P. Pandolfi,et al.  PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. , 2008, Genes & development.

[35]  R. Gilbertson,et al.  Making a tumour's bed: glioblastoma stem cells and the vascular niche , 2007, Nature Reviews Cancer.

[36]  Feifei Zhao,et al.  Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor. , 2007, Clinical immunology.

[37]  F. Levi-Schaffer,et al.  Role of reactive oxygen species (ROS) in apoptosis induction , 2000, Apoptosis.

[38]  G. Chamberlain,et al.  Induction , 2018, A Warning for Fair Women.

[39]  Shiyuan Cheng,et al.  The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes , 2017, Cell reports.

[40]  T. Cloughesy,et al.  Adult Glioblastoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Eilon D. Kirson,et al.  Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma , 2017 .

[42]  R. Geahlen,et al.  Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer. , 2015, Biochimica et biophysica acta.